Monitoring vital signs (VS) is a routine procedure in bone marrow transplant (BMT) units, but such monitoring can interfere with sleep. We hypothesized that middle of the night (MON) monitoring may not be needed in all patients. Charts of 20 consecutive patients who underwent BMT were reviewed for MON monitoring to determine the frequency with which monitoring resulted in a nursing intervention, call to the physician or change in treatment by the physician. Charts were also reviewed for day time events, which could predict the need for monitoring at night. MON monitoring was done on 457 of the 543 nights evaluated, l48 nursing interventions were performed during these 457 nights (32%) of which only 20 (4%) were the result of monitoring VS. In five instances, the nurse called the physician as a result of monitoring VS and in three of these five instances, the treatment was changed. The only day time event that was significantly associated was fever (P = 0.0002). There was also a trend for CNS events (P = 0.057) to be associated with MON intervention. Larger, prospective studies need to be done to accurately identify day time risk factors that can predict the need for night time monitoring. Bone Marrow Transplantation (2001) 27, 1197-1200.
Monitoring vital signs (VS) is a routine procedure in any critical care unit, including bone marrow transplant (BMT) units. Ordinarily, vital signs are monitored every 4 h round the clock during a patient's entire stay. Although giving valuable information about a patient's current physiologic status, such monitoring interferes with sleep of patients in the unit. We hypothesized that patients may not require routine middle of the night (MON) monitoring throughout their stay but rather may require round the clock monitoring only during certain times. We therefore undertook this study to determine the utility of continuous VS monitoring in a transplant unit, to determine the utility of MON VS monitoring and to ascertain whether VS monitoring could be restricted to certain times and days in particular patient populations. In order to do this, we evaluated the charts of all patients hospitalized within the previous 4 month period, evaluated all vital signs to determine when MON VS monitoring led to a medical intervention and tested whether day time factors predicted MON interventions.
Materials and methods

Patients
Twenty consecutive patients who underwent stem cell transplantation from August to November l998 made up the study population (Table 1) . The 20 patients evaluated in the BMTU had a mean age of 47.4 years ranging from 20 to 67 years. Nine were females and 11 were males. Their underlying diagnoses were acute lymphoblastic leukemia (three), acute myelogenous leukemia (four), chronic myelogenous leukemia (one), chronic lymphocytic leukemia (one), mixed lineage leukemia (one), multiple myeloma (three), non-Hodgkin's lymphoma (three) and breast cancer (two). Types of transplants were autologous (nine), matched related allogeneic (five) and matched unrelated donors (six), and type of stem cells used were peripheral blood (13) and bone marrow (seven) stem cells. In addition, all day time events that could serve as predictive factors for a need for VS monitoring were noted. In particular, the following day time symptoms were noted: pain, nausea, vomiting, diarrhea, other gastrointestinal complaints, and central nervous system (CNS) complaints which included disorientation, dizziness, tremors, lethargy, confusion and paresthesia. The following day time signs were also noted: fever, abnormal blood pressure, abnormal heart rate, respiratory rate, other respiratory findings, mucositis and rash. We also noted the following laboratory findings: abnormal potassium, magnesium and creatinine levels. Finally, we noted interventions during the day consisting of chemotherapy administration, antibiotics, steroids, total parenteral nutrition, transfusion, transfusion reaction and procedures such as central line placement or skin biopsy. These were later tested for an association with night time interventions resulting from abnormal VS in order to determine which of the day time events could be predictive for night time problems.
Protocols
The data extracted from the charts were reviewed to address the following questions: (1) how many times did VS monitoring result in a nursing intervention; (2) how many times did such monitoring result in a call to the physician, and (3) how many times did such monitoring result in a physician-driven change in therapy. Many interventions took place without physician notification because of supportive care guidelines written by the transplant physicians for specific interventions in response to specific events. Thus, in our BMT unit, nurses have pre-approved guidelines for treating fever, electrolyte abnormalities, anemia, thrombocytopenia and other common problems in otherwise stable patients.
Statistical analysis
The association of day time events with subsequent night time monitoring was assessed by chi-square analysis. A P value of less than 0.05 was considered statistically significant. Univariate analysis was done to determine which factors related to risk for night time intervention. All factors, regardless of univariate statistical significance, were then further evaluated for independent prognostic value by multivariate logistic regression analysis. Odds risk ratios for each of the prognostic variables were tested and statistical signficance noted.
Results
Night time monitoring resulting in nursing intervention
There were l48 MON interventions during the 457 nights evaluated. Of these, 128 did not relate to VS but rather to other events including pain, vomiting, diarrhea, dyspepsia, insomnia and abnormal blood counts or electrolyte values.
Only 20 (13.5%) of 148 night time interventions were due to monitoring VS at night ( Table 2 ). The rate of interventions for all nights monitored was 4% (20 interventions in a total of 457 nights). The abnormal vital signs that led to intervention at night included high temperature in l7 patients, bradycardia in two patients and hypertension in one patient. Ninety percent of these supportive care interventions took place between day 0 and day +21. In 15 instances the nurse made the intervention without calling a physician.
Night time monitoring resulting in call to physician
In five out of 20 instances a physician was called by the nurse. Patients who required a call to the doctor were diagnosed with MM (two), AML (two) and CML (one). All these calls occurred between day 0 and day +17 post transplant. These occurred in two patients undergoing autologous transplant, two patients undergoing matched related allogeneic transplant and in one patient undergoing MUD transplant. The reasons for these calls were bradycardia in two patients, hypertension in one patient, and fever in two patients (Table 2) .
Of the five patients for whom calls to physicians were made during the night, three patients required a change in treatment by the physician. The patients who needed a change in treatment had MM (two) and AML (one). Intervention was required on day +6 (one) for fever and vomiting and on day +13 (two) for bradycardia and hypertension. Interventions included were continuous monitoring for bra- (Table 2) .
Predictive value of day time events with need for night time monitoring
Day time events were then evaluated to determine if they could predict the need for monitoring of VS at night. All the day time events were recorded by review of the hospital record of each patient. These day time events were related to the night time intervention using chi-square analysis (see Table 3 ). There were two factors in the univariate analysis, which correlated with night time intervention. These were fever and abnormal heart rate. Only one of these (fever) was found to be independently significant (P = 0.0002). However, CNS complaints (ie disorientation, dizziness, tremors, lethargy, confusion and paresthesias) which were not significantly associated in univariate analysis (P = 0.49) were more significant as a prognostic factor when evaluated in multivariate analysis (P = 0.057). In multivariate analysis, the odds risk ratio of fever being associated with need for night time intervention was 51.3 (confidence interval of 6-408) and adjusted odds risk ratio for CNS events was 
Discussion
Sleeplessness is a major problem in BMT and other critical care units and can lead to impaired healing, memory loss, cognitive dysfunction and psychosis. [1] [2] [3] [4] [5] The reasons for insomnia include noise from beepers, monitors and pump alarms, light from room and hallways, pain, anxiety, and depression, or from nursing and medical procedures. One of the most common and regular interruptions of sleep is for VS monitoring, presumed in most units to be required for safe management of patients. Whether such routine monitoring is required, and whether the benefits from such monitoring outweigh the detriments of sleep deprivation, however, have not been studied.
Our study shows that VS monitoring may not be needed throughout each person's entire stay in a BMT unit. In only 4% (20 of 457 nights) did the MON VS result in a change in care. It is possible that MON VS monitoring could be restricted for high-risk situations if appropriate day time risk factors were known. This study suggests that certain signs can predict the need for night time problems, notably fever and CNS complaints. In our study, l8 of 20 patients who required night time intervention met one of these criteria. However, two patients who required night time intervention would have been missed with use of these two risk factors alone. Both of these patients had night time-associated bradycardia although neither required medical intervention other than observation. Other risk factors not revealed by this small pilot study may become apparent in Table 4 Day a larger study and may prove to define a still larger percentage of at risk patients requiring night time monitoring. Less rigorous monitoring of vital signs in a bone marrow transplant unit for lower risk patients could allow better sleep patterns in some patients recovering after BMT. Sleep promotes growth hormone production, 1 that in turn facilitates healing 6 as well as stem cell proliferation. 7 Deprivation of sleep interferes with immune system functioning, [8] [9] [10] glucose metabolism, 11 melatonin, growth hormone, cortisol and catecholamine levels, [11] [12] [13] [14] along with increased fatiguability, mood changes and decreased pain tolerance. 15, 16 There are also other advantages to less intensive monitoring during the night. One of these is saving of time and expense related to nursing activities. Another is the possibility of earlier discharge from an inpatient unit since patients can be monitored in an outpatient setting during the day and discharged home at night once the need for intense monitoring has passed. As outpatient BMT is considered a more feasible likelihood, this factor may become important in defining who is ready for discharge and who is not. 17 
